Microbot Medical (MBOT) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.95, -4.04% vs the prior close of $0.99.
- Volume 1.41M shares, 2.0x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MBOT slides 4.0% to $0.95, a 52-week low on 2.0x normal volume. Closed at $0.95, -4.04% vs the prior close of $0.99. Day range $0.93–$0.99, opened at $0.98.
MBOT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MBOT slides 4.0% to $0.95, a 52-week low on 2.0x normal volume
- Closed at $0.95, -4.04% vs the prior close of $0.99. Day range $0.93–$0.99, opened at $0.98.
- Volume was 1.41M shares, 2.0x its 50-day average of 687.25K — unusually heavy trading.
- Price is -31.8% vs its 50-day average ($1.39) and -50.2% vs its 200-day average ($1.91).
- 52-week range $0.93–$3.04; today's close sits at 1% of that range, 68.8% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 — MBOT dips 2.9% to $0.99, a 52-week low, 5 down days in a row
- Closed at $0.99, -2.94% vs the prior close of $1.02. Day range $0.99–$1.03, opened at $1.01.
- Volume was 568.20K shares, 0.8x its 50-day average of 688.83K.
- Price is -29.8% vs its 50-day average ($1.41) and -48.3% vs its 200-day average ($1.91).
- 52-week range $0.99–$3.04; today's close sits at 0% of that range, 67.4% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — MBOT dips 1.9% to $1.02, a 52-week low, 4 down days in a row
- Closed at $1.02, -1.92% vs the prior close of $1.04. Day range $1.01–$1.04, opened at $1.03.
- Volume was 383.20K shares, 0.6x its 50-day average of 688.69K — lighter than usual.
- Price is -28.6% vs its 50-day average ($1.43) and -46.9% vs its 200-day average ($1.92).
- 52-week range $1.01–$3.04; today's close sits at 0% of that range, 66.4% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — MBOT dips 2.8% to $1.04, a 52-week low, 3 down days in a row
- Closed at $1.04, -2.80% vs the prior close of $1.07. Day range $1.03–$1.08, opened at $1.07.
- Volume was 417.10K shares, 0.6x its 50-day average of 686.57K.
- Price is -27.9% vs its 50-day average ($1.44) and -46.0% vs its 200-day average ($1.93).
- 52-week range $1.03–$3.17; today's close sits at 0% of that range, 67.2% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — MBOT ends flat (+0.0%) to $1.07
- Closed at $1.07, +0.00% vs the prior close of $1.07. Day range $1.05–$1.09, opened at $1.08.
- Volume was 637.70K shares, 0.9x its 50-day average of 684.04K.
- Price is -26.5% vs its 50-day average ($1.46) and -44.6% vs its 200-day average ($1.93).
- 52-week range $1.05–$3.28; today's close sits at 1% of that range, 67.4% below the 52-week high.
Oct 8, 2026 — MBOT slides 4.5% to $1.07
- Closed at $1.07, -4.46% vs the prior close of $1.12. Day range $1.06–$1.15, opened at $1.12.
- Volume was 561.90K shares, 0.8x its 50-day average of 684.87K.
- Price is -27.2% vs its 50-day average ($1.47) and -44.7% vs its 200-day average ($1.94).
- 52-week range $1.05–$3.30; today's close sits at 1% of that range, 67.6% below the 52-week high.
Oct 7, 2026 — MBOT jumps 4.7% to $1.12
- Closed at $1.12, +4.67% vs the prior close of $1.07. Day range $1.07–$1.16, opened at $1.08.
- Volume was 639.90K shares, 0.9x its 50-day average of 686.43K.
- Price is -24.4% vs its 50-day average ($1.48) and -42.3% vs its 200-day average ($1.94).
- 52-week range $1.05–$3.35; today's close sits at 3% of that range, 66.6% below the 52-week high.
Oct 6, 2026 — MBOT ends flat (+0.0%) to $1.07 on 3.0x normal volume
- Closed at $1.07, +0.00% vs the prior close of $1.07. Day range $1.05–$1.17, opened at $1.09.
- Volume was 1.99M shares, 3.0x its 50-day average of 653.65K — unusually heavy trading.
- Price is -28.3% vs its 50-day average ($1.49) and -45.0% vs its 200-day average ($1.95).
- 52-week range $1.05–$3.46; today's close sits at 1% of that range, 69.1% below the 52-week high.
- That makes 10 straight losses.
- SEC filings that day: 8-K.
Oct 5, 2026 — MBOT slides 7.8% to $1.07, a 52-week low on 3.1x normal volume
- Closed at $1.07, -7.76% vs the prior close of $1.16. Day range $1.05–$1.16, opened at $1.15.
- Volume was 1.91M shares, 3.1x its 50-day average of 622.83K — unusually heavy trading.
- Price is -29.0% vs its 50-day average ($1.51) and -45.2% vs its 200-day average ($1.95).
- 52-week range $1.05–$3.46; today's close sits at 1% of that range, 69.1% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — MBOT slides 3.3% to $1.16, a 52-week low, 8 down days in a row
- Closed at $1.16, -3.33% vs the prior close of $1.20. Day range $1.14–$1.23, opened at $1.23.
- Volume was 846.40K shares, 1.4x its 50-day average of 614.52K.
- Price is -23.6% vs its 50-day average ($1.52) and -40.7% vs its 200-day average ($1.96).
- 52-week range $1.14–$3.46; today's close sits at 1% of that range, 66.5% below the 52-week high.
- That makes 8 straight losses.
MBOT latest news & SEC filings
Every SEC filing by or about MBOT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $241.00K
- Net income: -$5.63M (prior year -$3.50M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.08 (prior year -$0.10) (loss narrowed vs Jun 30, 2025)
Aug 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Things to know before you trade MBOT
- Last results release: Aug 15, 2017 (8-K Item 2.02). Previous ones: May 15, 2017, Mar 23, 2016, Nov 2, 2015. Based on that rhythm, the next report is likely around Nov 14, 2017 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.64% (largest 7.8%).
- Liquidity: about 772.81K shares (≈$734.17K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.95 vs a range of $0.93–$3.04 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 6, 2026; 8-K Sep 28, 2026; 8-K Aug 11, 2026.
- Share count: 67.16M shares outstanding (Aug 11, 2026), +47.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
MBOT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.98 | 0.99 | 0.93 | 0.95 | 1.41M |
| Oct 14, 2026 | 1.01 | 1.03 | 0.99 | 0.99 | 568.20K |
| Oct 13, 2026 | 1.03 | 1.04 | 1.01 | 1.02 | 383.20K |
| Oct 12, 2026 | 1.07 | 1.08 | 1.03 | 1.04 | 417.10K |
| Oct 9, 2026 | 1.08 | 1.09 | 1.05 | 1.07 | 637.70K |
| Oct 8, 2026 | 1.12 | 1.15 | 1.06 | 1.07 | 561.90K |
| Oct 7, 2026 | 1.08 | 1.16 | 1.07 | 1.12 | 639.90K |
| Oct 6, 2026 | 1.09 | 1.17 | 1.05 | 1.07 | 1.99M |
| Oct 5, 2026 | 1.15 | 1.16 | 1.05 | 1.07 | 1.91M |
| Oct 2, 2026 | 1.23 | 1.23 | 1.14 | 1.16 | 846.40K |
| Oct 1, 2026 | 1.21 | 1.23 | 1.18 | 1.20 | 683.00K |
| Sep 30, 2026 | 1.25 | 1.26 | 1.20 | 1.20 | 518.80K |
| Sep 29, 2026 | 1.27 | 1.28 | 1.22 | 1.25 | 631.40K |
| Sep 28, 2026 | 1.27 | 1.28 | 1.24 | 1.25 | 424.00K |
| Sep 25, 2026 | 1.32 | 1.33 | 1.26 | 1.28 | 482.90K |
| Sep 24, 2026 | 1.30 | 1.32 | 1.29 | 1.31 | 309.00K |
| Sep 23, 2026 | 1.39 | 1.39 | 1.31 | 1.31 | 461.00K |
| Sep 22, 2026 | 1.35 | 1.39 | 1.28 | 1.38 | 1.33M |
| Sep 21, 2026 | 1.36 | 1.39 | 1.34 | 1.35 | 566.10K |
| Sep 18, 2026 | 1.42 | 1.43 | 1.35 | 1.36 | 686.40K |
About Microbot Medical
Microbot Medical (MBOT) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in HINGHAM, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 883975.
MBOT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Scott R Burell | Director | Apr 3, 2026 |
| Harel Gadot | Chairman, President and CEO | Feb 20, 2026 |
| Prattipati Laxminarain | Director | Apr 3, 2026 |
| Martin J. Madden | Director | Apr 3, 2026 |
| Aileen Ptucha Stockburger | Director | Apr 3, 2026 |
| Tal Baruch Wenderow | Director | Apr 3, 2026 |
| David James Wilson | Director | Apr 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Juan Diaz-Cartelle | Chief Medical Officer | Feb 20, 2026 |
| Harel Gadot | Chairman, President and CEO | Feb 20, 2026 |
| Simon Sharon | General Manager, CTO | Feb 20, 2026 |
| Rachel Vaknin | Chief Financial Officer | Feb 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MBOT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-13.14M | -0.29 | $-13.05M |
| Dec 31, 2024 | — | $-11.44M | -0.73 | $-8.83M |
| Dec 31, 2023 | — | $-10.74M | -1.05 | $-8.53M |
| Dec 31, 2022 | — | $-13.17M | -1.81 | $-11.55M |
| Dec 31, 2021 | — | $-11.31M | — | $-9.35M |
Latest balance sheet: total assets $73.36M, total liabilities $4.44M, cash $3.15M (as of Jun 30, 2026).
MBOT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 15, 2017 | 8-K Item 2.02 (results) | — |
| May 15, 2017 | 8-K Item 2.02 (results) | — |
| Mar 23, 2016 | 8-K Item 2.02 (results) | — |
| Nov 2, 2015 | 8-K Item 2.02 (results) | — |
| Aug 6, 2015 | 8-K Item 2.02 (results) | — |
| May 5, 2015 | 8-K Item 2.02 (results) | — |
| Mar 16, 2015 | 8-K Item 2.02 (results) | — |
| Nov 6, 2014 | 8-K Item 2.02 (results) | — |
| Aug 12, 2014 | 8-K Item 2.02 (results) | — |
| May 14, 2014 | 8-K Item 2.02 (results) | — |
| Mar 12, 2014 | 8-K Item 2.02 (results) | — |
| Nov 5, 2013 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MBOT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.